Fibroblast growth factor 5 antigen (Genesis Research and Development/MorphoSys)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFibroblast growth factor 5 antigen (Genesis Research and Development/MorphoSys)
Drug Alias Nameanti-fibroblast growth factor 5 antibodiesZyrogen
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulatorsFibroblast growth factors antagonistsFibroblast growth factor receptors antagonists
TargetsFibroblast growth factorsFibroblast growth factor receptors
Therapy Area/IndicationsInflammationAutoimmune DiseasesLupus Erythematosus, Systemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenesis Research And Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenesis Research And Development
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesLupus Erythematosus, Systemic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A